Melatonin Glenmark Pharmaceuticals Europe

Melatonin, the active ingredient in Melatonin Glenmark Pharmaceuticals Europe, is a melatonin receptor agonist presented as an oral formulation for oral use. It helps regulate circadian rhythm and is used to manage insomnia and sleep‑wake rhythm disorders in adults.

GNH USA supplies Melatonin Glenmark Pharmaceuticals Europe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonin acts on the melatonin receptor system to address disorders of sleep initiation and circadian rhythm.

- Insomnia: improves sleep onset and reduces nighttime awakenings. - Sleep‑wake rhythm disorders: helps synchronize the internal clock to a normal schedule. - Shift work disorder: assists workers in adjusting sleep timing to irregular work hours. - Jet lag: shortens the time needed to adapt to new time zones. - Non‑24‑hour sleep‑wake disorder (blind individuals): promotes regular sleep‑wake cycles.

Melatonin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Drowsiness or daytime sleepiness. - Headache. - Dizziness. - Nausea or gastrointestinal discomfort. - Vivid dreams or nightmares. - Mild mood changes.

Serious or Rare Side Effects: - Allergic reactions such as rash, itching, or swelling. - Severe hypersensitivity including anaphylaxis. - Mood disturbances including depression or agitation. - Hallucinations or psychotic symptoms (rare). - Significant blood pressure changes. - Unexplained bleeding when combined with anticoagulants.

When considering melatonin therapy, several safety aspects should be reviewed.

- Pregnancy: consult a healthcare professional before use. - Breastfeeding: discuss potential risks with a physician. - Elderly patients: start with the lowest effective dose and monitor response. - Concomitant CNS depressants: watch for additive sedation. - Driving or operating machinery: avoid until the individual’s response to melatonin is known. - Store at ambient temperature below 25°C: keep in the original container, protect from moisture and direct sunlight.

Melatonin may interact with other medications, requiring attention to the level of risk.

Major Interactions (Avoid): - Warfarin or other anticoagulants: increased risk of bleeding. - Cyclosporine or other immunosuppressants: possible reduction in immunosuppressive effect. - Fluvoxamine: strong inhibition of melatonin metabolism, leading to elevated levels.

Moderate Interactions (Monitor Closely):\n- Caffeine: may diminish melatonin’s sleep‑promoting effect. - Alcohol: can enhance sedative properties and cause excessive drowsiness. - Benzodiazepines or other sedatives: increased central nervous system depression.